Oxford

Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Horsburgh K, Wardlaw JM, van Agtmael T, Allan SM, Ashford MLJ, Bath PM, Brown R, Berwick J, Cader MZ, Carare RO, Davis JB, Duncombe J, Farr TD, Fowler JH, Goense J, Granata A, Hall CN, Hainsworth AH, Harvey A, Hawkes CA, Joutel A, Kalaria RN, Kehoe PG, Lawrence CB, Lockhart A, Love S, Macleod MR, Macrae IM, Markus HS, McCabe C, McColl BW, Meakin PJ, Miller A, Nedergaard M, O'Sullivan M, Quinn TJ, Rajani R, Saksida LM, Smith C, Smith KJ, Touyz RM, Trueman RC, Wang T, Williams A, Williams SCR, Work LM.
Clin Sci (Lond).. 2018 132(8):851-868 . doi: https://doi.org/10.1042/CS20171620
PMID: 29712883

A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6.

Priestley RS, Cheung J, Murphy EJ, Ehebauer MT, Davis JB, Di Daniel E.
J Pharmacol Toxicol Methods. 2019 95:47-55 . doi: https://doi.org/10.1016/j.vascn.2018.11.003
PMID: 30476623

Microglial inflammation and phagocytosis in Alzheimer's disease: potential therapeutic targets.

Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E.
Br J Pharmacol. 2019 doi: https://doi.org/10.1111/bph.14618
PMID: 30740661

A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy.

Scholz J, Rathmell JP, David WS, Chad DA, Broderick AC, Perros SG, Shin NS, Wells JL, Davis JB, DiMaggio CJ, Wang S, Tate SN.
Pain. 2016 157(10):2297-2308 . doi: https://doi.org/10.1097/j.pain.0000000000000648
PMID: 27322439

Selective silencing of alpha-globin by the histone demethylase inhibitor IOX1: A potentially new pathway for treatment of beta-thalassemia.

Mettananda S, Fisher CA, Sloane-Stanley JA, Taylor S, Oppermann U, Gibbons RJ, Higgs DR.
Haematologica. 2016 doi: https://dx.doi.org/10.3324/haematol.2016.155655
PMID: 27810991

Structural basis for different specificities of acyltransferases associated with the human cytosolic and mitochondrial fatty acid synthases.

Bunkoczi G,Misquitta S,Wu X,Lee WH,Rojkova A,Kochan G,Kavanagh KL,Oppermann U,Smith S.
Chemistry & biology. 2009 doi: http://dx.doi.org/10.1016/j.chembiol.2009.04.011
PMID: 19549604

Development and application of a fluoride-detection-based fluorescence assay for gamma-butyrobetaine hydroxylase.

Rydzik AM,Leung IK,Kochan GT,Thalhammer A,Oppermann U,Claridge TD,Schofield CJ.
Chembiochem : a European journal of chemical biology. 2012 13(11):1559-1563 . doi: http://dx.doi.org/10.1002/cbic.201200256
PMID: 22730246

Kinetic and structural evidence of the alkenal/one reductase specificity of human zeta-crystallin.

Porté S, Moeini A, Reche I, Shafqat N, Oppermann U, Farrés J, Parés X.
Cellular and molecular life sciences. 2010 68(6):1065-1077 . doi: https://doi.org/10.1007/s00018-010-0508-2
PMID: 20835842

Comparison of the substrate selectivity and biochemical properties of human and bacterial gamma-butyrobetaine hydroxylase.

Rydzik AM,Leung IK,Kochan GT,Loik ND,Henry L,McDonough MA,Claridge TD,Schofield CJ.
Organic & biomolecular chemistry. 2014 12(33):6354-6358 . doi: http://dx.doi.org/10.1039/c4ob01167h
PMID: 25030770

SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy.

Ludwig C,Michiels PJ,Wu X,Kavanagh KL,Pilka E,Jansson A,Oppermann U,Gunther UL.
Journal of medicinal chemistry. 2008 51(1):1-3 . doi: http://dx.doi.org/10.1021/jm701020f
PMID: 18062662

Oxford

Pages